Group 1 - The company, Changfeng Pharmaceutical (02652), announced a share buyback on February 11, 2026, spending HKD 492,700 to repurchase 14,000 shares [1]

Group 1 - The company, Changfeng Pharmaceutical (02652), announced a share buyback on February 11, 2026, spending HKD 492,700 to repurchase 14,000 shares [1]

| 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 H | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02652 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | 事件 | | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | 庫存股份數目 | 每股發行/出售價 (註4) | 已發行股份總數 | | 於下列日期開始時的結存(註1) | 2026年2月10日 | 301,999,586 | | 224,000 | | 302,223,586 | | 1). 購回股份 (股份被持作庫存股份) | | -14,000 | 0.0046 % | 14,000 HKD | 35.1929 | | | 變動日期 2026年2月11日 | | | | | | | | 於下列日期結束時的 ...

Core Viewpoint - Changfeng Pharmaceutical (02652) announced a share buyback of approximately 10,500 shares at a cost of about HKD 370,500 on February 10, 2026 [1] Company Summary - The company executed a share repurchase, indicating a potential strategy to enhance shareholder value [1] - The total expenditure for the buyback was approximately HKD 370,500, reflecting the company's commitment to returning capital to shareholders [1]

Group 1 - The company, Changfeng Pharmaceutical (02652), announced a share buyback on February 10, 2026, costing approximately HKD 370,500 for 10,500 shares [1]

Group 1 - The company, Changfeng Pharmaceutical (02652.HK), announced a share buyback on February 10, spending HKD 370,000 to repurchase 11,000 shares [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 公司名稱： 長風藥業股份有限公司 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 H | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02652 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | 庫存股份數目 | 每股發行/出售價 (註4) | 已發行股份總數 | | 於下列日期開始時的結存(註1) | 2026年2月9日 | 302,010,086 | | 213,500 | | 302,223,586 | | 1). 購回股份 (股份被持作庫存股份) | | -10,500 | 0.0035 % ...

Group 1 - The company, Changfeng Pharmaceutical (02652), announced a share buyback on February 9, 2026, for a total expenditure of HKD 52.7 million [1] - A total of 1,500 shares were repurchased at a price range of HKD 35.08 to HKD 35.12 per share [1]

Group 1 - The company, Changfeng Pharmaceutical (02652), announced a share buyback on February 9, 2026, spending HKD 52.7 million to repurchase 1,500 shares [1] - The repurchase price per share ranged from HKD 35.08 to HKD 35.12 [1]

Group 1 - The company, Changfeng Pharmaceutical (02652.HK), announced a share buyback on February 9, 2023, spending HKD 53,000 to repurchase 1,500 shares [1]